RRx-001 followed by platinum plus etoposide in patients with previously treated small-cell lung cancer

导出原文传递

翻译打印收藏纠错

作者： Morgensztern, Daniel ^[1] ; Rose, Michal ^[2] ; Waqar, Saiama N. ^[3] ; Morris, John ^[4] ; Ma, Patrick C. ^[5] ; Reid, Thomas ^[6] ; Brzezniak, Christina E. ^[7] ; Zeman, Karen G. ^[8] ; Padmanabhan, Arvinda ^[9] ; Hirth, JoAnn ^[10] ; Spira, Alexander I. ^[11] ; Trepel, Jane B. ; Padda, Sukhmani K.

作者单位： Walter Reed Natl Mil Med Ctr, Bethesda, MD USA ^[1] Baptist Hlth, Lexington, KY USA ^[2] NCI, Bethesda, MD 20892 USA ^[3] Washington Univ, Sch Med, St Louis, MO 63110 USA ^[4] Mem Hosp, South Bend, IN USA ^[5] Univ Cincinnati, Canc Inst, Cincinnati, OH USA ^[6] West Virginia Univ, Morgantown, WV 26506 USA ^[7] VA Connecticut, West Haven, CT USA ^[8] Virginia Canc Specialists, Fairfax, VA USA ^[9] Henry Ford Allegiance Hlth, Jackson, MI USA ^[10] Stanford Univ, Sch Med, Stanford, CA 94305 USA ^[11]

发布时间 2019-11-26

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

The British journal of cancer

2019年121卷3期

211-217页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

RRx-001 followed by platinum plus etoposide in patients with previously treated small-cell lung cancer

The British journal of cancer

相似文献

The British journal of cancer

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

RRx-001 followed by platinum plus etoposide in patients with previously treated small-cell lung cancer

The British journal of cancer

相似文献

The British journal of cancer

相关期刊

检索历史清除